3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.08.28
关于美国全资子公司雇主养老金计划投资的公告
2014.08.28
2014年半年度财务报告
2014.08.28
第三届董事会第三次会议决议公告
2014.08.28
关于召开2014年第三次临时股东大会的通知公告
2014.08.28
董事会关于募集资金2014年半年度存放与使用的专项报告
2014.08.28
关于公司使用自有资金购买低风险理财产品的公告
2014.08.28
关于公司及美国全资子公司向银行申请授信额度的公告
2014.07.31
2014年半年度业绩快报
2014.07.29
2014年第二次临时股东大会决议公告
2014.07.29
2014年第二次临时股东大会的法律意见书
第一页
上一页
109
110
111
112
113
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.